Selected urticaria patients benefit from a referral to tertiary care centres - Results of an expert survey

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 1, 2013, Pages

  Weller, K ^a   Schoepke, N ^a   Krause, K ^a   Ardelean, E ^a   Brautigam M ^b   Maurer, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Novartis Pharma   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OMALIZUMAB; STEROID;

ACUTE SPONTANEOUS URTICARIA; ARTICLE; CHOLINERGIC URTICARIA; CHRONIC SPONTANEOUS URTICARIA; COST; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; FEMALE; FOLLOW UP; GERMANY; HUMAN; INTERVIEW; MALE; PATIENT REFERRAL; PHYSICAL URTICARIA; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; URTICARIA;

ADULT; AGED; CHRONIC DISEASE; CYCLOSPORINE; DERMATOLOGY; FEMALE; GERMANY; HEALTH CARE SURVEYS; HISTAMINE ANTAGONISTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RISK ASSESSMENT; TERTIARY CARE CENTERS; TREATMENT OUTCOME; URTICARIA;

EID: 84872870578     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04387.x     Document Type: Article

References (28)

1. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426.
2. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-1443.
3. 2LEN task force report. Allergy 2011; 66: 317-330.
4. O'Donnell B, Lawlor F, Simpson J, Morgan M, Greaves M,. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
5. Grob J, Revuz J, Ortonne J, Auquier P, Lorette G,. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005; 152: 289-295.
6. Młynek A, Magerl M, Hanna M, et al. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009; 64: 927-936.
7. Delong L, Culler S, Saini S, Beck L, Chen S,. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients. Arch Dermatol 2008; 144: 35-39.
8. Kapp A, Demarteau N,. Cost effectiveness of levocetirizine in chronic idiopathic urticaria: a pooled analysis of two randomised controlled trials. Clin Drug Investig 2006; 26: 1-11.
9. Weller K, Viehmann K, Bräutigam M, et al. Cost intensive, time consuming, problematical?-How physicians in the practice setting experience care of urticaria patients. J Dtsch Dermatol Ges 2011 Nov 23. doi: 10.1111/j.1610-0387.2011.07822.x.
10. Weller K, Viehmann K, Bräutigam M, et al. Management of chronic spontaneous urticaria in real life-In accordance with the guidelines? A cross-sectional physician based survey study. submitted to J Eur Acad Dermatol Venereol doi: 10.1111/j.1468-3083.2011.04370.x [Epub ahead of print].
11. Maurice-Tison S, Pouyanne J, Doutre MS,. General practitioners, dermatologists, allergists, and the management of chronic urticaria. Results of a practice survey. Ann Dermatol Venereol 2003; 130 (Spec No 1): 1S160-1S173.
12. van der Valk P, Moret G, Kiemeney L,. The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre. Br J Dermatol 2002; 146: 110-113.
13. Kozel M, Mekkes J, Bossuyt P, Bos J,. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 2001; 45: 387-391.
14. Hirschmann JV, Lawlor F, English JS, Louback JB, Winkelmann RK, Greaves MW,. Cholinergic urticaria. A clinical and histologic study. Arch Dermatol 1987; 123: 462-467.
15. Katsarou-Katsari A, Makris M, Lagogianni E, Gregoriou S, Theoharides T, Kalogeromitros D,. Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol 2008; 22: 1405-1411.
16. Kozel MM, Bossuyt PM, Mekkes JR, Bos JD,. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review. J Am Acad Dermatol 2003; 48: 409-416.
17. Wedi B, Raap U, Wieczorek D, Kapp A,. Urticaria and infections. Allergy Asthma Clin Immunol 2009; 5: 10.
18. Zuberbier T, Chantraine-Hess S, Hartmann K, Czarnetzki BM,. Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol 1995; 75: 484-487.
19. Magerl M, Pisarevskaja D, Scheufele R, Zuberbier T, Maurer M,. Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial. Allergy 2010; 65: 78-83.
20. Metz M, Giménez-Arnau A, Borzova E, Grattan C, Magerl M, Maurer M,. Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria. J Allergy Clin Immunol 2009; 123: 705-706.
21. Konstantinou G, Asero R, Maurer M, Sabroe R, Schmid-Grendelmeier P, Grattan C,. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009; 64: 1256-1268.
22. Di Lorenzo G, Pacor ML, Mansueto P, et al. Food-additive-induced urticaria: a survey of 838 patients with recurrent chronic idiopathic urticaria. Int Arch Allergy Immunol 2005; 138: 235-242.
23. Staevska M, Popov T, Kralimarkova T, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 2010; 125: 676-682.
24. Giménez-Arnau A, Izquierdo I, Maurer M,. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009; 23: 1088-1091.
25. Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M,. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 2009; 123: 672-679.
26. Asero R,. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatol 2007; 32: 34-38.
27. Zuberbier T, Ifflander J, Semmler C, Henz BM,. Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol 1996; 76: 295-297.
28. Pollack CV Jr, Romano TJ,. Outpatient management of acute urticaria: the role of prednisone. Ann Emerg Med 1995; 26: 547-551.